🕊️ $BEAM Of Hope

Plus, where did the 'Napa Valley of cannabis' go wrong?

March 11, 2025

Happy Tuesday afternoon to everyone on The Street. Here's a snapshot of where markets ended the trading session, plus tomorrow's trade idea delivered to you today.

Sponsored by Boxabl

Did you know that car factories, like Ford, can output one car per minute? Why hasn't anyone done that in the housing industry?

Before BOXABL, the concept of building houses in a factory seemed impractical. With their patented shipping technology, merging housing with assembly line mass production could be a game-changer. Investing in BOXABL on StartEngine is closing soon. Join 40,000 investors, invest in BOXABL today.

Disclosure: *This is a paid advertisement for Boxabl’s Regulation A offering. Please read the offering circular here. This is a message from Boxabl

S&P 500 Heatmap. Credit: Finviz

All Stock Heatmap. Credit: Finviz

Global ADR snapshot. Credit: Finviz

MARKET MOVERS

Asana, Verizon, Reddit

$ASAN ( ▲ 0.61% ) Asana CEO Dustin Moskovitz announces retirement, stock plummets (CNBC)

$VZ ( ▼ 0.07% ) Verizon CRO issues warning on competitive landscape, softening demand (SeekingAlpha)

$RDDT ( ▼ 2.29% ) Why Reddit Stock Just Popped (The Motley Fool)

$KSS ( ▼ 1.63% ) Kohl’s Shares Fall After Weak Sales Outlook (WSJ)

$TER ( ▼ 3.39% ) Teradyne Stock Is Today’s Worst Performer in the S&P 500. Tariffs Are 1 Reason. (Barron’s)

OVERHEARD ON THE STREET

CNBC: Trump said he would hike tariffs on Canadian steel and aluminum to 50% in response to Ontario's 25% tax on US electricity exports, but seemed to walk it back later in the day after the province’s premier suspended the retaliatory tariff.

WSJ: Wall Street fears Trump's recent signals of indifference to trade uncertainty and rising risks will derail a potential soft landing.

Reuters: US job openings rose in January while layoffs declined, but labor demand is expected to soften amid concerns over Trump's policy shifts.

CNN: Two recent plane crashes, including a fatal American $AAL ( ▼ 3.95% ) crash and a Delta flight incident, have led to a pullback in air travel, airlines say.

Bloomberg: Health Secretary RFK Jr. gave food companies an ultimatum to remove artificial dyes.

TOMORROW’S TRADE IDEA, TODAY

$BEAM Of Hope

Beaming With Pride

It’s not every day a stock sees a 60% price target raise. But it’s not every day a company has a breakthrough like BEAM Therapeutics $BEAM ( ▲ 0.09% ) just had.

Phase I/II trial findings are in for the biotech firm’s experimental single-base DNA editing therapies, designed to treat AATD, a rare genetic disorder with no known cure. The results? Single-base editing seems to work, with limited side effects.

As a result, Scotiabank $BNS ( ▼ 1.26% ) hiked its target price for the stock from $25 to $40. That represents an upside of more than 50% from today’s close.

Uncertain Market, Underappreciated Opportunity

It’s been a rocky start to the year for traditional “growth stocks”, such as big tech mega-caps and AI plays. The sell-off continued today, with some of the biggest blue-chip stocks now trading down double-digit percentages YTD.

Amid similar routs, some investors will turn toward the healthcare industry and related sectors like biotechnology. Demand for these non-discretionary expenses may not fluctuate much in a downturn, and innovation in the sector might be less stymied by otherwise far-reaching market forces.

That could be why Scotiabank is calling BEAM “an underappreciated market opportunity” — even in an uncertain market.

Cure for the Common Portfolio

Zooming out, it hasn’t exactly been a banner year for the sector, either.

The Medical-Biomed/Genetics Market has slumped more than 8% over the past 12 months, according to Zacks Investment Research, and BEAM has been hit especially hard. Its shares have fallen nearly 30% in the same period.

If Scotiabank is correct, that could just mean this is the ideal time to buy into an innovative company with a potential cure for a rare disease — and, perhaps, your portfolio’s woes.

Are you bullish or bearish on BEAM Therapeutics (BEAM) over the next 12 months?

Login or Subscribe to participate in polls.

Sponsored by VantagePoint

Breaking A.I. analysis has just unveiled THREE POTENTIAL "STRATEGIC OPTIONS OPPORTUNITIES" set to emerge this March.

But why does this matter now?

Because these movements usually suggest significant institutional positioning behind the scenes.

One particular security shows a high level of professional accumulation.

When institutions move with this level of conviction, strategic traders should take notice.

Position yourself ahead of these anticipated market movements.

ON OUR RADAR

CNBC: Trump called a Tesla boycott "illegal" and announced he plans to buy one of the EVs to support Elon Musk.

BI: Speaking of, Tesla owners looking to sell amid the backlash may see a sharp loss, as used prices of the EVs have dropped by nearly $10,000 to around $30,000.

Barron’s: Shares of Beacon Roofing Supply $BECN ( ▼ 0.03% ) are on the rise as an initially unwanted deal appears to be turning into a desirable transaction.

NYT: Former Philippine President Duterte was arrested and flown to The Hague to face ICC charges of crimes against humanity related to his drug war.

WSJ: Pueblo, Colorado once hoped to become the "Napa Valley of cannabis". What went wrong?

MONDAY’S POLL RESULTS

Will the US economy see a recession in 2025?

🟩🟩🟩🟩🟩🟩 Yes

🟨🟨🟨⬜⬜⬜ No

And, in response, you said:

  • Yes —

    • “A recession is needed to bring down the price of everything.”

    • “Long overdue…”

    • “Thank Donny Trump for it. It's the economy, stupid.”

  • No — 

    • “Growth will continue at about 2-3% YoY.”

    • “Trump will cave.”

Last Words From Our Sponsors

This message is a paid advertisement for Boxabl Inc. The Street Sheet (SS) receives a flat fee from Ad Astra Media totaling up to $5,250. Other than the compensation received for this advertisement sent to subscribers, The Street Sheet and its principals are not affiliated with Boxabl Inc. This advertisement is sponsored by a third-party Reg A crowdfunding issuer and is for informational purposes only. The Street Sheet does not endorse or recommend any specific offering, and this advertisement should not be construed as a recommendation to invest. Investing in securities, including those offered through Reg A crowdfunding, involves risk, including the potential loss of principal. These investments are speculative, illiquid, and may involve a higher degree of risk compared to more traditional investments. The Street Sheet has not verified the information provided by the advertiser, and we encourage readers to conduct their own due diligence and consult with a licensed financial advisor or other qualified professional before making any investment decision. By engaging with this advertisement, you acknowledge that The Street Sheet and its affiliates are not responsible for any decisions or actions taken based on the information provided in this advertisement. All investments carry risks, and past performance is not indicative of future results. Readers should carefully review all information provided by the issuer, including the offering circular and any other available materials, prior to investing. The Street Sheet may receive compensation from the advertiser for promoting this offering. The Street Sheet and its principals do not own any of the stocks or shares mentioned in this email or in the article that this email links to. The Street Sheet is a research service not owned or managed by registered brokers and therefore this site does not make any investment recommendations. The information provided in this newsletter is not guaranteed as to its accuracy or completeness. Each user of SS chooses to do trades at their sole discretion and risk. SS is not responsible for gains/losses that may result in the trading of these securities. This newsletter includes paid advertisements. The source of all third-party content in which SS receives some sort of compensation is clearly and prominently identified herein as "ad", "Sponsored", or “Together With”. Although we have sent you these advertisements, SS does not specifically endorse any third-party product nor is it responsible for the content, the accuracy, or the completeness of the advertisement or the experience with the third-party advertiser. Furthermore, we make no guarantee or warranty about what is in the advertisement. All investments involve risk, losses may exceed the principal invested, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. This communication from The Street Sheet is for informational purposes only. It is not intended to serve as a recommendation to buy, sell, or hold any security and is not an offer or sale of a security. Information contained within should not be perceived as a research report and is not intended to serve as the basis for any investment decision. Any third-party views reflected herein do not reflect the opinion of The Street Sheet. All investments involve risk and the past performance of a security does not guarantee future results or returns. There is always the potential for financial loss when investing in securities or other financial products. The information contained in this newsletter is subject to change without notice, and we do not undertake any obligation to update it. Readers are encouraged to conduct their own research and due diligence and seek advice from licensed professionals regarding their specific financial needs and circumstances. By reading this newsletter, you agree to hold us harmless from any and all losses, liabilities, costs, or expenses arising from your use or reliance on the information provided. There is no warranty as to the accuracy or completeness of the factual matters included in any advertisement or sponsored content in the newsletter. You have not performed any research on any entity, or its business, that advertises or submits any sponsored content. The Street Sheet is reader-supported. When you buy through links on our site, we may earn a commission.

Reply

or to participate.